Imunon, Inc.

IMNN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$19-$20-$36-$21
Dep. & Amort.$1$1$1$1
Deferred Tax$1$0-$0$0
Stock-Based Comp.$0$1$3$4
Change in WC-$3-$2$2-$1
Other Non-Cash-$0$1$8$1
Operating Cash Flow-$19-$19-$23-$16
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$0-$14-$48-$54
Inv. Sales/Matur.$10$25$57$24
Other Inv. Act.$0$0$0$0
Investing Cash Flow$10$11$8-$30
Financing Activities
Debt Repay.$0-$6$0$1
Stock Issued$9$3$7$53
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$2
Financing Cash Flow$9-$4$7$55
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$12-$8$8
Supplemental Information
Beg. Cash$6$17$26$17
End Cash$6$6$17$26
Free Cash Flow-$19-$19-$23-$17
Imunon, Inc. (IMNN) Financial Statements & Key Stats | AlphaPilot